 prognost factor advanc head neck cancer patient undergo multimod therapi retrospect analysi potenti prognost factor complet remiss neoadjuv chemotherapi overal surviv patient stage iii stage IV head neck cancer eighti consecut patient studi cours neoadjuv chemotherapi local therapi surgeri and/or radiotherapi complet remiss strong signific independ predictor complet remiss nodal stage complet remiss node-neg patient remiss rate less import predictor tumor stage site diseas nasopharyng patient superior remiss rate median followup month surviv rate median month individu factor surviv pretherapi weight loss perform statu alcohol use pretherapi serum albumin level site diseas stage multivari weight loss independ predictor surviv health statu measur perform statu serum level addit stage alcohol use predict cross-classif stage weight loss risk group differ prognos use design analysi futur trial